Patents by Inventor Yen-Tung Luan

Yen-Tung Luan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12054762
    Abstract: Methods of producing a protein in cell culture comprising an anti-senescence compound, such as the antioxidant carnosine, are provided. According to teachings of the present invention, cells grown in a cell culture medium comprising an anti-senescence compound exhibit increased viability and productivity. Furthermore, cell cultures grown in the presence of an anti-senescence compound exhibit decreased levels of high molecular weight aggregates in the cell culture medium.
    Type: Grant
    Filed: April 22, 2008
    Date of Patent: August 6, 2024
    Assignee: WYETH LLC
    Inventors: Jose Manuel Gomes, Yen-Tung Luan, Gregory Walter Hiller, Wenge Wang
  • Publication number: 20230416674
    Abstract: A cell culture medium comprising tyrosine at a concentration of at least 3 mM and polyvinylalcohol (PVA).
    Type: Application
    Filed: August 31, 2023
    Publication date: December 28, 2023
    Applicant: Pfizer Inc.
    Inventors: Bruno FIGUEROA, Yen-Tung Luan, Wenge Wang
  • Publication number: 20190112572
    Abstract: A cell culture medium comprising tyrosine at a concentration of at least 3 mM and polyvinylalcohol (PVA).
    Type: Application
    Filed: March 23, 2017
    Publication date: April 18, 2019
    Applicant: Pfizer Inc.
    Inventors: Bruno FIGUEROA, Yen-Tung Luan, Wenge Wang
  • Patent number: 9012180
    Abstract: An improved system for large scale production of polypeptides in cell culture is provided. In accordance with the present invention, cells expressing a polypeptide of interest are grown in media that contain copper, glutamate or both. The use of such a system allows production of polypeptides in which misfolding and/or aggregation are reduced, and in which total glycosylation is increased. Polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical, agricultural or other commercial compositions.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: April 21, 2015
    Assignee: Wyeth LLC
    Inventors: Denis Drapeau, Jessica Snow, Gregory Hiller, Yen Tung Luan
  • Publication number: 20140322758
    Abstract: The present invention provides, among other things methods of increasing cell density, viability and/or titer in a cell culture including steps of adding a composition comprising iron to the cell culture.
    Type: Application
    Filed: October 9, 2012
    Publication date: October 30, 2014
    Inventors: Wenge Wang, Yen-Tung Luan, Denis Drapeau
  • Publication number: 20130084593
    Abstract: This invention relates to methods for rationally designing cell culture media for use in cell cultures, e.g., cell cultures employed in polypeptide production; cell culture media designed with the disclosed methods; methods of producing a polypeptide of interest, e.g., an antibody, using such media; polypeptides produced using the methods and media disclosed herein; and pharmaceuticals compositions containing such polypeptides. The rationally designed media contain a concentration of an amino acid that is calculated for use in cell mass, a concentration of the amino acid that is calculated for use in cell maintenance, and a concentration of the amino acid that is calculated for incorporation into the polypeptide of interest.
    Type: Application
    Filed: July 30, 2012
    Publication date: April 4, 2013
    Applicant: Wyeth LLC
    Inventors: Yen-Tung Luan, Wenge Wang, Ryan Nolan, Denis Drapeau
  • Patent number: 8232075
    Abstract: This invention relates to methods for rationally designing cell culture media for use in cell cultures, e.g., cell cultures employed in polypeptide production; cell culture media designed with the disclosed methods; methods of producing a polypeptide of interest, e.g., an antibody, using such media; polypeptides produced using the methods and media disclosed herein; and pharmaceuticals compositions containing such polypeptides. The rationally designed media contain a concentration of an amino acid that is calculated for use in cell mass, a concentration of the amino acid that is calculated for use in cell maintenance, and a concentration of the amino acid that is calculated for incorporation into the polypeptide of interest.
    Type: Grant
    Filed: November 8, 2007
    Date of Patent: July 31, 2012
    Assignee: Wyeth LLC
    Inventors: Yen-Tung Luan, Wenge Wang, Ryan Nolan, Denis Drapeau
  • Patent number: 8192951
    Abstract: An improved system for large scale production of proteins and/or polypeptides in cell culture is provided. In accordance with the present invention, cells expressing the protein or polypeptide of interest are grown in media that comprise a glycolysis-inhibiting substance. Additionally and/or alternatively, cells expressing the protein or polypeptide of interest are grown in media in which glutamine is limited. The use of such a system allows high levels of protein or polypeptide production and lessens accumulation of undesirable metabolic waste products such as lactate. Proteins and polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical, immunogenic, agricultural or other commercial compositions.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: June 5, 2012
    Assignee: Wyeth LLC
    Inventors: Wenge Wang, Yen Tung Luan
  • Patent number: 8039231
    Abstract: Methods and processes for improved recombinant protein production are provided. The methods are useful for production of growth factors, particularly those of the TGF-? superfamily, including bone morphogenetic proteins (BMPs), such as BMP-2. Suitable host cells are cultured in media where iron is present at a concentration of at least 2.25 ?M and if pyridoxal is present, it makes up less than 55% of the molar concentration of vitamin B6 in the media.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: October 18, 2011
    Assignee: Wyeth LLC
    Inventors: Yen-Tung Luan, Wenge Wang, Gregg Nyberg, Jose Manuel Gomes, Denis Drapeau, Terry Cardoza
  • Publication number: 20090317867
    Abstract: Methods and processes for improved recombinant protein production are provided. The methods are useful for production of growth factors, particularly those of the TGF-? superfamily, including bone morphogenetic proteins (BMPs), such as BMP-2. Suitable host cells are cultured in media where iron is present at a concentration of at least 2.25 ?M and if pyridoxal is present, it makes up less than 55% of the molar concentration of vitamin B6 in the media.
    Type: Application
    Filed: April 16, 2009
    Publication date: December 24, 2009
    Applicant: Wyeth, Madison, New Jersey
    Inventors: Yen-Tung Luan, Wenge Wang, Gregg Nyberg, Jose Manuel Gomes, Denis Drapeau, Terry Cardoza
  • Publication number: 20090068705
    Abstract: An improved system for large scale production of polypeptides in cell culture is provided. In accordance with the present invention, cells expressing a polypeptide of interest are grown in media that contain copper, glutamate or both. The use of such a system allows production of polypeptides in which misfolding and/or aggregation are reduced, and in which total glycosylation is increased. Polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical, agricultural or other commercial compositions.
    Type: Application
    Filed: February 29, 2008
    Publication date: March 12, 2009
    Applicant: Wyeth
    Inventors: Denis Drapeau, Jessica Snow, Gregory Hiller, Yen Tung Luan
  • Publication number: 20080274507
    Abstract: Methods of producing a protein in cell culture comprising an anti-senescence compound, such as the antioxidant carnosine, are provided. According to teachings of the present invention, cells grown in a cell culture medium comprising an anti-senescence compound exhibit increased viability and productivity. Furthermore, cell cultures grown in the presence of an anti-senescence compound exhibit decreased levels of high molecular weight aggregates in the cell culture medium.
    Type: Application
    Filed: April 22, 2008
    Publication date: November 6, 2008
    Applicant: WYETH
    Inventors: Jose Manuel Gomes, Yen-Tung Luan, Gregory Walter Hiller, Wenge Wang
  • Patent number: 7429491
    Abstract: Methods of improving protein production in animal cell cultures are provided. Cell culture methods are presented wherein glucose is fed in a restricted manner to cell culture; this restricted feeding of glucose to the cell culture results in lactate production being controlled to a low level. The restricted feeding of glucose in a fed-batch process is not accomplished through a constant-rate feeding of glucose, and the restricted feeding need not depend on sampling. Instead, restricted feeding of glucose to the culture is accomplished through feeding of glucose to the culture at a rate that is a function of an expected or a premodeled rate of glucose consumption by the animal cells when exposed to medium containing a high level of glucose. Because lactate production is controlled to low levels, recombinant protein production is increased.
    Type: Grant
    Filed: May 17, 2004
    Date of Patent: September 30, 2008
    Assignee: Wyeth
    Inventors: Yen-Tung Luan, Terry Cardoza Stanek, Denis Drapeau
  • Publication number: 20080108553
    Abstract: This invention relates to methods for rationally designing cell culture media for use in cell cultures, e.g., cell cultures employed in polypeptide production; cell culture media designed with the disclosed methods; methods of producing a polypeptide of interest, e.g., an antibody, using such media; polypeptides produced using the methods and media disclosed herein; and pharmaceuticals compositions containing such polypeptides. The rationally designed media contain a concentration of an amino acid that is calculated for use in cell mass, a concentration of the amino acid that is calculated for use in cell maintenance, and a concentration of the amino acid that is calculated for incorporation into the polypeptide of interest.
    Type: Application
    Filed: November 8, 2007
    Publication date: May 8, 2008
    Inventors: Yen-Tung Luan, Wenge Wang, Ryan Nolan, Denis Drapeau
  • Patent number: 7335491
    Abstract: An improved system for large scale production of proteins and/or polypeptides in cell culture, particularly in media characterized by one or more of: i) a cumulative amino acid concentration greater than about 70 mM; ii) a molar cumulative glutamine to cumulative asparagine ratio of less than about 2; iii) a molar cumulative glutamine to cumulative total amino acid ratio of less than about 0.2; iv) a molar cumulative inorganic ion to cumulative total amino acid ratio between about 0.4 to 1; or v) a combined cumulative glutamine and cumulative asparagine concentration between about 16 and 36 mM, is provided. The use of such a system allows high levels of protein production and lessens accumulation of certain undesirable factors such as ammonium and/or lactate. Additionally, culture methods including a temperature shift, typically including a decrease in temperature when the culture has reached about 20-80% of it maximal cell density, are provided.
    Type: Grant
    Filed: August 25, 2005
    Date of Patent: February 26, 2008
    Assignee: Wyeth Research Ireland Limited
    Inventors: Denis Drapeau, Yen-Tung Luan, James R. Mercer, Wenge Wang, Daniel R. Lasko
  • Patent number: 7300773
    Abstract: An improved system for large scale production of proteins and/or polypeptides in cell culture, particularly in media characterized by one or more of: i) a cumulative amino acid concentration greater than about 70 mM; ii) a molar cumulative glutamine to cumulative asparagine ratio of less than about 2; iii) a molar cumulative glutamine to cumulative total amino acid ratio of less than about 0.2; iv) a molar cumulative inorganic ion to cumulative total amino acid ratio between about 0.4 to 1; or v) a combined cumulative glutamine and cumulative asparagine concentration between about 16 and 36 mM, is provided. The use of such a system allows high levels of protein production and lessens accumulation of certain undesirable factors such as ammonium and/or lactate. Additionally, culture methods including a temperature shift, typically including a decrease in temperature when the culture has reached about 20-80% of it maximal cell density, are provided.
    Type: Grant
    Filed: August 25, 2005
    Date of Patent: November 27, 2007
    Assignee: Wyeth Research Ireland Limited
    Inventors: Denis Drapeau, Yen-Tung Luan, James R. Mercer, Wenge Wang, Daniel R. Lasko
  • Patent number: 7294484
    Abstract: An improved system for large scale production of proteins and/or polypeptides in cell culture, particularly in media characterized by one or more of: i) a cumulative amino acid concentration greater than about 70 mM; ii) a molar cumulative glutamine to cumulative asparagine ratio of less than about 2; iii) a molar cumulative glutamine to cumulative total amino acid ratio of less than about 0.2; iv) a molar cumulative inorganic ion to cumulative total amino acid ratio between about 0.4 to 1; or v) a combined cumulative glutamine and cumulative asparagine concentration between about 16 and 36 mM, is provided. The use of such a system allows high levels of protein production and lessens accumulation of certain undesirable factors such as ammonium and/or lactate. Additionally, culture methods including a temperature shift, typically including a decrease in temperature when the culture has reached about 20-80% of it maximal cell density, are provided.
    Type: Grant
    Filed: August 25, 2005
    Date of Patent: November 13, 2007
    Assignee: Wyeth Research Ireland Limited
    Inventors: Denis Drapeau, Yen-Tung Luan, James R. Mercer, Wenge Wang, Daniel R. Lasko
  • Publication number: 20070110743
    Abstract: Methods of producing a protein in cell culture comprising an anti-senescence compound, such as the antioxidant carnosine, are provided. According to teachings of the present invention, cells grown in a cell culture medium comprising an anti-senescence compound exhibit increased viability and productivity. Furthermore, cell cultures grown in the presence of an anti-senescence compound exhibit decreased levels of high molecular weight aggregates in the cell culture medium.
    Type: Application
    Filed: October 24, 2006
    Publication date: May 17, 2007
    Applicant: Wyeth
    Inventors: Denis Drapeau, Yen-Tung Luan, Paul Thoday, Wenge Wang, Judy Chou
  • Publication number: 20060160180
    Abstract: An improved system for large scale production of proteins and/or polypeptides in cell culture, particularly in media characterized by one or more of: i) a cumulative amino acid concentration greater than about 70 mM; ii) a molar cumulative glutamine to cumulative asparagine ratio of less than about 2; iii) a molar cumulative glutamine to cumulative total amino acid ratio of less than about 0.2; iv) a molar cumulative inorganic ion to cumulative total amino acid ratio between about 0.4 to 1; or v) a combined cumulative glutamine and cumulative asparagine concentration between about 16 and 36 mM, is provided. The use of such a system allows high levels of protein production and lessens accumulation of certain undesirable factors such as ammonium and/or lactate. Additionally, culture methods including a temperature shift, typically including a decrease in temperature when the culture has reached about 20-80% of it maximal cell density, are provided.
    Type: Application
    Filed: August 25, 2005
    Publication date: July 20, 2006
    Applicant: Wyeth Research Ireland Limited
    Inventors: Denis Drapeau, Yen-Tung Luan, James Mercer, Wenge Wang, Daniel Lasko
  • Publication number: 20060121568
    Abstract: An improved system for large scale production of proteins and/or polypeptides in cell culture, particularly in media characterized by one or more of: i) a cumulative amino acid concentration greater than about 70 mM; ii) a molar cumulative glutamine to cumulative asparagine ratio of less than about 2; iii) a molar cumulative glutamine to cumulative total amino acid ratio of less than about 0.2; iv) a molar cumulative inorganic ion to cumulative total amino acid ratio between about 0.4 to 1; or v) a combined cumulative glutamine and cumulative asparagine concentration between about 16 and 36 mM, is provided. The use of such a system allows high levels of protein production and lessens accumulation of certain undesirable factors such as ammonium and/or lactate. Additionally, culture methods including a temperature shift, typically including a decrease in temperature when the culture has reached about 20-80% of it maximal cell density, are provided.
    Type: Application
    Filed: August 25, 2005
    Publication date: June 8, 2006
    Applicant: Wyeth Research Ireland Limited
    Inventors: Denis Drapeau, Yen-Tung Luan, James Mercer, Wenge Wang, Daniel Lasko